Comparison of oxidative stress markers in type 2 diabetes: Basal bolus therapy versus twice daily premixed insulin analogs

Masaki Sakamoto, Gaku Inoue, Kaoru Tsuyusaki, Kensuke Usui, Miwako Watanabe, Junichiro Irie, Koichiro Atsuda, Satoru Yamada

研究成果: Article査読

3 被引用数 (Scopus)

抄録

Aims: Several studies have shown that twice-daily injection of premixed insulin analog (MIX) therapy achieves glycemic control equivalent to that with basal-bolus (BB) therapy. However, glycemic fluctuations that lead to oxidative stress may be associated with the risk of diabetic complications. Therefore, in this study, we compared oxidative stress markers between MIX therapy and BB therapy. Methods: In this cross-sectional study, we recruited a total of 37 patients (17 patients in the BB group and 20 patients in the MIX group) and compared urinary 8-isoprostane and urinary 8-hydroxydeoxyguanosine (8-OHdG) levels. Results: There were no significant differences in urinary 8-isoprostane (BB vs MIX: 199±92 pg/mg Cr vs 266±107 pg/mg Cr) or urinary 8-OHdG (4.7±1.6 ng/mg Cr vs 5.4±1.9 ng/mg Cr, respectively). Conclusion: These results suggest that MIX is equivalent to BB in terms of glycemic fluctuations and oxidative stress.

本文言語English
ページ(範囲)355-359
ページ数5
ジャーナルInternal Medicine
49
5
DOI
出版ステータスPublished - 2010

ASJC Scopus subject areas

  • 内科学

フィンガープリント

「Comparison of oxidative stress markers in type 2 diabetes: Basal bolus therapy versus twice daily premixed insulin analogs」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル